Newsletter | May 13, 2022

05.13.22 -- 5 Life Sciences Trends To Watch
 
New Podcast Episode
Featured Articles
5 Life Science Trends To Watch
 

During the pandemic, clinical trials were impacted as people avoided unnecessary interactions with healthcare. As the nation continues to adjust, here are five trends that will change the way medical solutions are developed and administered.
A Nigerian Student’s Striking Pictures Illustrate Lessons We All Must Learn
 

Academia and industry must transform how we see skin — and how the medical field represents diverse identities.
How Can Digital Technology Improve The Treatment Of Neurological Disorders?
 

See the answer from John Reynders, VP, R&D strategy, program management, data science at Alexion Pharmaceuticals.
Web-Exclusive Content
FDA Issues Guidance On Initiation Of Voluntary Recalls
 

This guidance supports the requirements of 21 CFR Part 7 Enforcement Policy for drugs, medical devices, and biological products, and is being issued consistent with FDA's good guidance practices regulation. You may submit comments regarding this guidance to the agency at any time. 
Take The Tufts CSDD Pharma/Biotech Patient Engagement Survey
 

Tufts CSDD is conducting an important new survey to assess how pharma and biotech companies are incorporating patient engagement into their drug development organizations and operations. Take the survey here.
Industry Insights
FAQs: In Vitro Diagnostic Medical Device Regulation

On May 26, 2017, the EU Regulation 2017/746 of the European Parliament and the Council on in vitro diagnostic medical devices (IVDR) became active under the EU Regulation on Medical Devices (MDR). Discover answers regarding the expected changes in this blog.
Improving The Supply Of Single-Use Technologies

The use of single-use technologies has been growing steadily over the past decade, but there are challenges. Explore the potential solutions for single-use supply constraints.
Technology And Clinical Monitoring

Clinical trials are evolving due to multiple forces that are affecting what was once a very standard approach. This notion of change has been constantly streaming into monitoring processes and the clinical monitoring role.
Digital Edition
May 2022 Digital Edition
 

Inside you will find more on:

  • Companies To Watch
  • R&D
  • Executing An IPO
  • Psychedelic Therapies

View the digital edition.
Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.